{"id":"W4409670273","doi":"10.1016/j.jhepr.2025.101431","title":"Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Imperial Experimental Cancer Medicine Centre; European Association for the Study of the Liver; Associazione Italiana per la Ricerca sul Cancro; Foundation for Liver Research; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Treatment and Research Trust; Cancer Research UK; Wellcome Trust; F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Bevacizumab; Medicine; Internal medicine; Oncology; Nivolumab; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188355,0.0002209704,0.003973335,0.000608024,0.0000494402,0.00001211475,0.00007891406,0.00006724524,0.0001445475],"category_scores_gemma":[0.001195847,0.0001505438,0.00138466,0.001693126,0.00005956819,0.00007787735,0.00005500151,0.00006620478,7.928983e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001086678,"about_ca_system_score_gemma":0.0002456194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000513864,"about_ca_topic_score_gemma":0.000100353,"domain_scores_codex":[0.9974009,0.0001299485,0.001517683,0.0004234803,0.0003301958,0.0001978025],"domain_scores_gemma":[0.9969531,0.0007159319,0.0008763467,0.0009831112,0.0003814183,0.00009013486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0003426246,0.0003309406,0.07489268,0.6566621,0.2650158,0.0003899343,0.0002011852,0.000009970263,0.000269298,0.00067849,0.001113762,0.00009317451],"study_design_scores_gemma":[0.0005660219,0.0001803197,0.00422547,0.008347375,0.9833783,0.00004315231,0.00001254068,0.0004274269,0.002540705,0.00005697981,0.00009801974,0.0001237194],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2668521,0.7082235,0.0004010092,0.002337838,0.00009498171,0.01525567,0.00006414275,0.00009355129,0.006677272],"genre_scores_gemma":[0.9852991,0.003141925,0.0004804584,0.0001243352,0.000006411562,0.0006090417,0.00005403985,0.00001468876,0.01027008],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7184469,"threshold_uncertainty_score":0.6138997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1545571557431444,"score_gpt":0.3669817862430308,"score_spread":0.2124246304998864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}